1 / 72

Cocaine-induced chest pain Focus on Acute coronary syndromes

Cocaine-induced chest pain Focus on Acute coronary syndromes. Daniel Brouillard, R3 McGill Emergency Medicine December 12 2001. Objectives. What is the prevalence of ACS/AMI in cocaine users? What is the role of the EKG in the diagnosis of ACS in this particular patient population?

Thomas
Download Presentation

Cocaine-induced chest pain Focus on Acute coronary syndromes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cocaine-inducedchest painFocus on Acute coronary syndromes Daniel Brouillard, R3 McGill Emergency Medicine December 12 2001

  2. Objectives • What is the prevalence of ACS/AMI in cocaine users? • What is the role of the EKG in the diagnosis of ACS in this particular patient population? • What is the most beneficial approach to management based on the current litterature? • What is the role of reperfusion therapy in these patients?

  3. Plan • Cocaine 2) Cocaine associated-C/P 3) Cocaine-related myocardial ischemia

  4. Cocaine • Erythroxylon coca • Benzoylmethylecgonine (cocaine) • Primarly grown in South America • Hydrochloride salt • « free base »

  5. History • 3000 B.C. Coca leaves are chewed in South America, believed to be a gift from God. • 1400’s Coca plantations operated by Incas. • 1662 First indepedent mention of coca in the English litterature: « A legend of Coca » by Abraham Coley. • 1850 Coca tinctures used in throat surgery. • 1855 Cocaine is first extracted from coca leaves. • 1870 Vin Mariani is for sale in Europe, in contains 6mg of cocaine per ounce of wine.

  6. History (continued) • 1884 Sigmund Freud publishes « On Coca » in witch he recommends the use of cocaine in the treatment of various conditions. • 1886 Introduction of Coca-Cola: contains cocaine syrup. • 1895 First cases of associated deaths reported in the Lancet. • 1912 5000 cocaine related fatalities per year • 1914 Harrison’s Narcotics Act • 1970’s -80’s Days of Glory • Mid-80’s Freebase cocaine( crack)

  7. . Presentation and pharmacology

  8. Onset and duration of action

  9. Effects 1) Sodium channel blocking properties (Quinidine-Like) 2) Systemically, blocks the re-uptake of amines in the synapse.

  10. Excretion • Metabolised by liver and plasma esterase • Ecgonyl methyl ester (30-50%) • Benzylecgonine (40%) • Detection possible in urine - Free cocaine : 6h - Benzylecgonine : up to 72 h.

  11. Cocaethylene • 2 substances often consummed together • Product of combination of cocaine and ET-OH in the liver. • Dose related myocardial depression in dogs. • Longer half life • Could account for delayed presentation.

  12. Part II

  13. Cocaine and people • 30 million American at least one time users • 5 million current users • 160,000 visits per year in the USA • Statistiques Canada 1994: close to 2% of Canadian population are current users

  14. Prevalence-Questions • In cocaine users who present to the ED, how many will have a major complaint of C/P ? • How many of these patients have ACS ? • How many of these patients have AMI ?

  15. Hollander and al. Annals of emergency medicine 1994 • Prevalence of cocaine use in patients older then 18 y presenting with C/P • 359 patients • Anonymous urine collection on everybody • Found 20 % prevalence in urban area • Prevalence of 7% at the rural sites • 28% of positives denied use when questioned

  16. Rich, Annals of EM, June 1991« Cocaine related Symptoms in patients presenting to the ED » • 146 patients • Retrospective chart review • Overall prevalence 16% for C/P (23 patients) • Total of 3 patients admitted • Stronger association with nasal route (11/23)

  17. Brody, Am. Journal of medicine, 1990« Cocaine-related medical problems » • 233 patients • Retrospective chart review • 40% prevalence of C/P • Most had acute complaints(3 h<) • Overall mortality 1%

  18. Cocaine related complaints

  19. Differential diagnosis • Cardiomyopathy • Myocarditis • Pulmonary embolus or thrombus • Pneumonia • Endocarditis • Aotic dissection • Pneumothorax, pneumopericardium, pneumomediastinum • ACS

  20. Differential diagnosis(2) • Most articles discuss the prevalence of AMI/ACS. • Case reports • Most C/P will, in the end, have a benign diagnosis.

  21. Prevalence studies-Cocaine MI

  22. Problems • Subjected to reporting bias • All studies done on inpatients. • No studies use Troponin. • Small amount of long term follow-up. • Population difficult to follow as outpatient

  23. AMI vs ACS • All studies essentially look at incidence of MI. Questions: • Acute event in a otherwise normal coronary? • Prevalence of actual CAD ? • Prevalence of Acute Coronary Syndromes? • Reversible ischemia?

  24. People with chest painUsers vs non-users • American Survey 1995-1996 • 4639 chest pain visits • In the general population( ages 25-40) • 5.6% of C/P in ED will be ACS • 2.5% prevalence of AMI Burt, Am. Jour. Of Emerg. Med, October 1999

  25. Epidemiology • High proportion is male ( 70-80%) • Mostly African-American • Median age : 35 yo • Cardiac risk similar vs control • High concommitant use of cigarettes • More likely to be admitted to ICU/CCU • Cost of 83 millions $$$$$$

  26. Dangers of body-packing

  27. Third Nationnal Health and Nutrition survey 10 085 patients aged 18-45 yo 731 infrequent users 532 frequent users ( about 5% of population) 46 non fatal MI’s HNADES III ’88-’94 Results: 1) OR 6.9 for frequent users. CI95% 1.3 to 58 2) OR 0.1 infrequent users. CI95% 0.002 to 0.8 *More smokers, HTN Frequent vs non-frequent users

  28. Time to presentation Mittleman and al., Circulation 99 • 3946 MI patients • 38 admitted to cocaine use • 9 within 1h of MI • 1within 2h of MI • 1 within 3h of MI • RR 23.7 in the first hour

  29. Prevalence of ACS • Feldman, Annals of emergency med. 1999 -241 patients over 2 years. - High risk (69) went directly to CCU. - Moderate and low risk had tehcnicium99 sestamibi done in the following 90 min. - 6 MI’s (6/218= 2.5%) or 8.7% of CCU patients - Stress studies on 70 patients: 6 reversible ischemia (6/67= 8.6%) at follow-up. - No recurrence at 30 days

  30. CAD vs Non-CAD events ? • Review articles : 31 to 67% have CAD. • Hollander , Meta-analysis, 1997 - 66 patients with cocaine-associated MI - Angio-proven CAD in 41% of patients - Presence of other risk factors NOT associated with greater incidence of CAD.

  31. Complications/ short term • Reported in the prospective studies: 5-10% • One study designed to look at complications: - Hoffman, Archives of internal med, 1995 - Retrospective study of 130 patients with MI. - 36% had complications - 90% within 12 h of presentation - 48% on arrival to the ED

  32. Complications

  33. Mortality • Feldman 2000 : 0% • Weber 2000: 0% • Hoffman 1995: 0% • Hollander 1994: 0% -No study reports death following arrival to the hospital.

  34. In summary • Up to 40% of cocaine-related complaints • Young population • Smokers • Delayed presentation • Frequent users are more at risk • Most complications occur within 12h • Very low mortality

  35. In summary(2) • 6% prevalence of AMI in most studies. • Prevalence of ACS is not known • Maybe close to 9-10% • 30 to 67% of these patients have CAD

  36. PART III

  37. Animal testing

  38. Part III Cocaine- related ACS • Pathophysiology • Diagnosis • Treatment • Conclusion

  39. Pathophysiology 1) Increased workload on the heart • Sympathomimetic state • Increased afterload • Increased myocardial O2 needs. Impact: Rise in BP of 20/10mmHg Rise in HR of 30 beats/min Equivalent to mild exercise at recretionnal doses. ( 2 mg/kg).

  40. Pathophysiology(2) • Coronary vasoconstriction • Most human studies use doses 2mg/kg 1-4 • Effect starts at 3-5 min Decrease in diameter of 4% to 29% • Effect is worse on diseased arteries. 5 • Presence of temporal variations • 1)Lange and al., N Engl J Med 1989;321:1557-62.2 )Flores ED, Am Coll Cardiol 1990;16:74-9.3)Molnerto DJ, N Engl J Med 1994;330:454-9. 4)Majid MJ, Clin Cardiol 1992;15:253-8.5)Daniel WC, Am J Cardiol 1996;78:288-91

  41. Pathophysiology(3) • Thrombosis and platelet aggregation. - Cocaine associated to thrombus in coronary arteries in some of the AMI cases. - Angiographic and pathologic evidence.1-4 - Mecanism is believed to be expression of thrombogenic substances in-situ 1)Simpson RW, Arch Pathol Lab Med 1986;110:479-84. 2)Cooke CT, Pathology 1988;20:242, 305-6 3)Patel GQ, Circulation 1988;78(II Suppl):II436 4)Steinberg RG,Arch Pathol Lab Med 1989;113:521-4

  42. Pathophysiology (4) • Accelerated intracoronary atherosclerosis - Wilson and al, J Emerg Med 1998;16:631-4. - Review of previous series and 2 new cases. #1 Significant LAD lesion over 10 months #2 Significant 3 vessel disease over 16 months - Rapid progression in chronic abusers. - Recurrence of ACS with continuous use.

  43. Pathophysiology

  44. Evaluation • History and physical examination. • EKG • Cardiac enzymes

  45. History and physical exam • Unable to differentiate between the various causes on the basis of the clinical evaluation. - Localisation - Quality - Associated symptoms - Pleuritic component * 28% of patients with MI had a pleuritic component. *Hofffman, Academic emergency med, 1994

  46. EKG • Primary determinent to thrombolysis in AMI. • Sensitivity: 54-89% ( 95% CI ) • Specificity: 67-96% Do these findings apply to cocaine-induced chest pain?

  47. EKG (2) • Gitter and al., Annals of int. Medicine, 1991 - Serie of 101 patients with cocaine-C/P - 43% met TIMI criteria for reperfusion. - NO AMI found • Tokarski, Ann. of emerg. Med, 1990 - Serie of 42 patients - All normal EKG’s - 19% of patients had CK-MB elevation

  48. EKG (3) • Pitfalls : - High prevalence of repolarisation abnormalities in young population. (BER). - Presence of repolarisation abnormalities in cocaine users without C/P. - Higher incidence of left ventricular hypertrophy in cocaine users.

More Related